Avise Analytics is the fastest growing equity research firm that authors institutional quality equity research reports, with special focus on Nano-Cap and Micro-Cap companies that are undervalued and lacks adequate coverage.
Our team of highly experienced analysts provides a wide range of tailored services in the field of equity, investment and financial research and investor relations to our diversified client base around the world.
Our free mobile app gives you real-time notifications on publication of short company stories for compelling investment ideas so that you never miss an opportunity!
As a step to effectively handle your research team’s workload as a business partner, our free mobile (and tablet friendly) application, also offer you a complete accessibility in tracking your project progress and billing and payment status at the tip of your finger any time.
Download the app for free now to explore our talent pool and feel the difference in outsourcing your work to us.
We pride ourselves in constantly delivering high-quality and scalable equity, investment and credit research solutions to our diversified client base across 9 countries. A snapshot of our key experience in past 3 years includes:
Boxlight Corporation (NASDAQ: BOXL), a leading education technology Company offering interactive solutions for the educa...20 July, 2020No comment
GenMark Diagnostics (NASDAQ: GNMK), a Company developing molecular diagnostic tests based on its proprietary eSensor ele...24 March, 2020No comment
Aleafia Health (OTCQX: ALEAF), a wholly owned subsidiary of Aleafia Farms Inc, announced that the Company’s Ontario–...23 March, 2020No comment
Agenus Inc (NASDAQ: AGEN), a clinical-stage immune-oncology company developing innovative therapies for treatment of can...19 March, 2020No comment
Cancer is the second leading cause of death in the U.S, next only to heart diseases. An estimated 1.7 million new cancer...17 March, 2020No comment
TOMI Environmental Solutions (OTCQB: TOMZ), a Company that offers indoor and outdoor disinfection and decontamination se...16 March, 2020No comment
Charlotte’s Web Holdings (OTCQX: CWBHF), a pioneer in hemp-derived CBD products, announced the completion of an audit ...13 March, 2020No comment
RADA Electronic Industries (NASDAQ: RADA), a global defense technology Company offering leading-edge radar solutions and...12 March, 2020No comment
Fennec Pharmaceuticals (NASDAQ: FENC), a small–stage biotechnology Company, announced the grant of a patent 10,596,190...11 March, 2020No comment
Zosano Pharma (NASDAQ: ZSAN), a clinical-stage biopharmaceutical Company, announced the acceptance of the Company’s Ne...06 March, 2020No comment
Altimmune Inc (NASDAQ: ALT), a clinical stage biotechnology Company developing immunotherapies for unmet medical needs, ...05 March, 2020No comment
Zelira Therapeutics (OTCQB: ZLDAF), a biopharmaceutical Company developing cannabinoid-based formulations for the treatm...04 March, 2020No comment
Fabry Disease also known as angiokeratoma corporis diffusum or alpha-galactosidase A deficiency, is an inherited disorde...03 March, 2020No comment
Avise Analytics is a professionally managed organization and understood job scopes & requirements very well. The report and analysis generated meet my expectations and will not hesitate to recommend others.
Delivered a high-quality set of documents that exceeded my expectations. Keep up the good work!!
Great team. We ramped up our coverage universe quickly due to their help. I highly recommend them!
High quality equity research provider that we now use for regular work
Excellent communication skills and a high commitment to client satisfaction.
Instrumental in helping us complete the research in such a tight timeline!
I have found Avise Analytics to be a great, cost-effective solution to providing both simple and complex finance-related articles for various blogs and newsletters. They are detailed oriented, consciences, respond well to direction, prompt and really know the finance industry.